144 related articles for article (PubMed ID: 22964504)
1. Platelet-activating factor (PAF) antagonistic activity of a new biflavonoid from Garcinia nervosa var. pubescens King.
Jalil J; Jantan I; Ghani AA; Murad S
Molecules; 2012 Sep; 17(9):10893-901. PubMed ID: 22964504
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor (PAF) receptor binding activity of the roots of Enicosanthellum pulchrum.
Nordin N; Jalil J; Jantan I; Murad S
Pharm Biol; 2012 Mar; 50(3):284-90. PubMed ID: 22103812
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of compounds from Goniothalamus tapis Miq. and Goniothalamus uvaroides King on platelet-activating factor receptor binding.
Moharam BA; Jantan I; Jalil J; Ahmad F
Phytother Res; 2012 May; 26(5):687-91. PubMed ID: 22002630
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor (PAF) receptor binding antagonist activity of the methanol extracts and isolated flavonoids from Chromolaena odorata (L.) King and Robinson.
Ling SK; Pisar MM; Man S
Biol Pharm Bull; 2007 Jun; 30(6):1150-2. PubMed ID: 17541171
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet aggregation and platelet activating factor (PAF) receptor antagonistic activities of the essential oils of five Goniothalamus species.
Moharam BA; Jantan I; Ahmad Fb; Jalil J
Molecules; 2010 Jul; 15(8):5124-38. PubMed ID: 20714290
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of acetylmelodorinol, chrysin and polycarpol from Mitrella kentii on prostaglandin E₂ and Thromboxane B₂ production and platelet activating factor receptor binding.
Saadawi S; Jalil J; Jasamai M; Jantan I
Molecules; 2012 Apr; 17(5):4824-35. PubMed ID: 22538486
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibitory effect of rubraxanthone isolated from Garcinia parvifolia on platelet-activating factor receptor binding.
Jantan I; Pisar MM; Idris MS; Taher M; Ali RM
Planta Med; 2002 Dec; 68(12):1133-4. PubMed ID: 12494345
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants.
Jantan I; Rafi IA; Jalil J
Phytomedicine; 2005 Jan; 12(1-2):88-92. PubMed ID: 15693713
[TBL] [Abstract][Full Text] [Related]
9. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin.
Hsu HC; Yang WC; Tsai WJ; Chen CC; Huang HY; Tsai YC
Biochem Biophys Res Commun; 2006 Jul; 345(3):1033-8. PubMed ID: 16712790
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of kaempferol against binding of platelet activating factor to its receptor].
Zang BX; Jin M; Wu W; Chen WM; Piao YZ; Li JR
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):789-91. PubMed ID: 15506296
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
Takehara S; Mikashima H; Muramoto Y; Terasawa M; Setoguchi M; Tahara T
Prostaglandins; 1990 Dec; 40(6):571-83. PubMed ID: 1965554
[TBL] [Abstract][Full Text] [Related]
12. Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation.
Lee LW; Peng HC; Ko WC; Hung WC; Su CH; Lin CH; Huang TF; Yen MH; Sheu JR
Eur J Pharmacol; 1999 Jan; 364(2-3):239-46. PubMed ID: 9932729
[TBL] [Abstract][Full Text] [Related]
13. A new biflavonoid from leaves of Garcinia nervosa.
Parveen M; Ilyas M; Mushfiq M; Busudan OA; Muhaisen HM
Nat Prod Res; 2004 Jun; 18(3):269-75. PubMed ID: 15143839
[TBL] [Abstract][Full Text] [Related]
14. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
Salari H; Dryden P; Howard S; Bittman R
Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
[TBL] [Abstract][Full Text] [Related]
15. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.
Li J; Huang H; Miezan Ezoulin JM; Gao XL; Massicot F; Dong CZ; Heymans F; Chen HZ
Int J Neuropsychopharmacol; 2007 Feb; 10(1):21-9. PubMed ID: 16426477
[TBL] [Abstract][Full Text] [Related]
17. A specific, photolabile and irreversible antagonist (L662,025) of the PAF-receptor.
Hussaini IM; Shen TY
Biochem Biophys Res Commun; 1989 May; 161(1):23-30. PubMed ID: 2543410
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo effects of SR 27417, a novel PAF antagonist, on rabbit platelet aggregation and [3H]-PAF binding.
Herbert JM; Laplace MC; Maffrand JP
J Lipid Mediat; 1992 Feb; 5(1):1-12. PubMed ID: 1327264
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of platelet-activating factor-induced platelet activation by oleic acid is associated with a decrease in polyphosphoinositide metabolism.
Nunez D; Randon J; Gandhi C; Siafaka-Kapadai A; Olson MS; Hanahan DJ
J Biol Chem; 1990 Oct; 265(30):18330-8. PubMed ID: 2170407
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
